Report copyright - STATISTICAL ANALYSIS PLAN - ClinicalTrials.gov...ReveraGen BioPharma, Inc. FINAL Version 1.0 Study VBP15-002 Statistical Analysis Plan 2018-01-31 IND#: 118,942 CONFIDENTIAL Page |
Please pass captcha verification before submit form